SEVOFLURANE  BAXTER 100 %  INHALATION VAPOUR LIQUID Israel - inglés - Ministry of Health

sevoflurane baxter 100 % inhalation vapour liquid

baxter healthcare distribution ltd., israel - sevoflurane - liquid for inhalation - sevoflurane 100 %v/v - sevoflurane - sevoflurane is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.

Flumazenil-Baxter flumazenil 1 mg/10 mL solution for injection ampoule Australia - inglés - Department of Health (Therapeutic Goods Administration)

flumazenil-baxter flumazenil 1 mg/10 ml solution for injection ampoule

baxter healthcare pty ltd - flumazenil, quantity: 1 mg - injection, solution - excipient ingredients: disodium edetate; sodium chloride; water for injections; sodium hydroxide; glacial acetic acid - flumazenil-baxter is indicated for use in hospitalised patients for the reversal of acute benzodiazepine effects (overdose or therapeutic). hospitalised patients are patients admitted to hospital, inpatient care and under continued professional observation while under the influence of flumazenil-claris. not to be used in outpatients or short stay patients. not to be used as a diagnostic.

Flumazenil-Baxter flumazenil 0.5 mg/5 mL solution for injection ampoule Australia - inglés - Department of Health (Therapeutic Goods Administration)

flumazenil-baxter flumazenil 0.5 mg/5 ml solution for injection ampoule

baxter healthcare pty ltd - flumazenil, quantity: 0.5 mg - injection, solution - excipient ingredients: water for injections; sodium hydroxide; disodium edetate; glacial acetic acid; sodium chloride - flumazenil-baxter is indicated for use in hospitalised patients for the reversal of acute benzodiazepine effects (overdose or therapeutic). hospitalised patients are patients admitted to hospital, inpatient care and under continued professional observation while under the influence of flumazenil-claris. not to be used in outpatients or short stay patients. not to be used as a diagnostic.

KETAMINE-BAXTER ketamine (as hydrochloride) 200 mg/2 mL solution for injection ampoule Australia - inglés - Department of Health (Therapeutic Goods Administration)

ketamine-baxter ketamine (as hydrochloride) 200 mg/2 ml solution for injection ampoule

baxter healthcare pty ltd - ketamine hydrochloride, quantity: 115.34 mg/ml (equivalent: ketamine, qty 100 mg/ml) - injection, solution - excipient ingredients: water for injections; nitrogen - ketamine-baxter is recommended: 1. as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. ketamine-claris is best suited for short procedures and it can be used with additional doses, for longer procedures; 2. for the induction of anaesthesia prior to the administration of other general anaesthetic agents; 3. to supplement low-potency agents, such as nitrous oxide.

BUPIVACAINE-BAXTER bupivacaine hydrochloride (as monohydrate) 50 mg/10 mL solution for injection vial Australia - inglés - Department of Health (Therapeutic Goods Administration)

bupivacaine-baxter bupivacaine hydrochloride (as monohydrate) 50 mg/10 ml solution for injection vial

baxter healthcare pty ltd - bupivacaine hydrochloride, quantity: 5 mg/ml (equivalent: bupivacaine hydrochloride monohydrate, qty 5.28 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; sodium hydroxide; water for injections - indications ,bupivacaine-baxter is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: ,surgical anaesthesia ,epidural block for surgery ,field block (minor and major nerve blocks and infiltration). ,analgesia ,continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. ,field block (minor nerve block and infiltration).

BUPIVACAINE-BAXTER bupivacaine hydrochloride (as monohydrate) 50 mg/20 mL solution for injection vial Australia - inglés - Department of Health (Therapeutic Goods Administration)

bupivacaine-baxter bupivacaine hydrochloride (as monohydrate) 50 mg/20 ml solution for injection vial

baxter healthcare pty ltd - bupivacaine hydrochloride, quantity: 2.5 mg/ml (equivalent: bupivacaine hydrochloride monohydrate, qty 2.64 mg/ml) - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium chloride; sodium hydroxide - indications ,bupivacaine-baxter is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: ,surgical anaesthesia ,epidural block for surgery ,field block (minor and major nerve blocks and infiltration). ,analgesia ,continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. ,field block (minor nerve block and infiltration).

FUROSEMIDE-BAXTER SOLUTION FOR INJECTION 20 MG2 ML Singapur - inglés - HSA (Health Sciences Authority)

furosemide-baxter solution for injection 20 mg2 ml

baxter healthcare (asia) pte ltd - furosemide - injection, solution - furosemide 20 mg/2 ml

SODIUM CHLORIDE AND GLUCOSE Irlanda - inglés - HPRA (Health Products Regulatory Authority)

sodium chloride and glucose

baxter healthcare limited - sodium chloride; glucose monohydrate - solution for infusion - 0.18/4 %w/v - electrolytes in combination with other drugs

Antithrombin III Baxter 50 I.U./ml, powder and solvent for solution for injection or infusion Malta - inglés - Malta Medicines Authority

antithrombin iii baxter 50 i.u./ml, powder and solvent for solution for injection or infusion

baxter healthcare limited - antithrombin iii 50 iu/ml - powder and solvent for solution for infusion or injection

Suprane Inhalation vapour, solution Irlanda - inglés - HPRA (Health Products Regulatory Authority)

suprane inhalation vapour, solution

baxter healthcare limited - desflurane - inhalation vapour, solution - 100 percent volume/volume - halogenated hydrocarbons; desflurane